← All Intercure LTD filings

Intercure LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
INCR
Intercure LTD
20-F: InterCure 2025 Annual Report: Recovery and Growth
InterCure reports 2025 financial results, highlighting recovery efforts at its Southern Facility and continued expansion.
NASDAQ
INCR
Intercure LTD
20-F: InterCure Ltd. Announces Equity Incentive Plan and Financial Reporting Details in Form 20-F Filing
InterCure Ltd. details its equity incentive plan, financial results, and compliance with regulatory requirements in its latest Form 20-F filing.
NASDAQ
INCR
Intercure LTD
20-F: Intercure Ltd. Reports Fiscal Year 2023 Results Amidst Regional Challenges
Intercure Ltd. announces its fiscal year 2023 financial results, highlighting revenue of NIS 356 million and Adjusted EBITDA of NIS 53 million, while navigating the impacts of the war in Gaza.